All companies › PTIX

PTIX · Protagenic Therapeutics, Inc.\new

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

1
Open-market buys
0
Open-market sells
0
INSIDER SCANNER signals
2026-08-05
Last filing

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

SEC Form 4 filings

Every open-market transaction disclosed for PTIX in the synced window. Values are the insider's own, as filed.

DateInsiderTitleTypeSharesPriceValue
2026-08-05 ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Open-market buy 5,000 0.26 $1,294

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.